Consolidated management report as of 30 September 2023
Insider information as of 30 September 2023
Additional information as of 30 September 2023
Consolidated financial report according to BFSC standards as of 30 September 2023
Information according to Annex 4 of Ordinance 2 as at 30 September 2023
Declaration by the responsible directors as at 30 September 2023
Consolidated financial report according to IFRS as of 30 September 2023 -Excel
Notification on the terms and conditions for distribution of the dividend
Sofia, Bulgaria, November 24, 2023 – In accordance with the requirements of art. 115c, para. 4 of LPOS “Sopharma” AD notifies all shareholders of the Company about the decision of the EGM of “Sopharma” AD that took place on November 24, 2023 regarding the amount and type of dividend distributed and the terms and conditions for its distribution:
The EGM approves the proposal by the Board of Directors for the distribution of 6-month gross dividend amounting to BGN 0.90 (ninety stotinki) per share.
Sales revenues for October 2023
Sofia, Bulgaria, November 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for the month of October 2023, the Company realized an increase in sales of 45% compared to the same month of the previous year, incl. 53% increase in domestic sales and 42% increase in export sales.
For the ten months from the beginning of 2023, sales increased by a total of 18%, incl. a 5% increase in domestic sales and a 27% increase in export sales.